| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = -$68,698 ) |
| | 2024 | 2022 | APRICITY THERAPEUTICS, INC. | 953 INDIANA ST | SAN FRANCISCO | CA | 94107-3007 | SAN FRANCISCO | USA | R43FD007586 | Intestinal Drug Transporters in Veterinary Animals | 000 | 1 | FDA | 4/29/2024 | -$68,698 |
|
| Issue Date FY: 2023 ( Subtotal = $0 ) |
| | 2023 | 2020 | APRICITY THERAPEUTICS, INC. | 953 INDIANA ST | SAN FRANCISCO | CA | 94107-3007 | SAN FRANCISCO | USA | R43FD006909 | Drug Transporters in Farm Animals | 000 | 1 | FDA | 4/27/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $168,400 ) |
| | 2022 | 2022 | APRICITY THERAPEUTICS, INC. | 953 INDIANA ST | SAN FRANCISCO | CA | 94107-3007 | SAN FRANCISCO | USA | R43FD007586 | Intestinal Drug Transporters in Veterinary Animals | 000 | 1 | FDA | 9/26/2022 | $168,400 |
| | 2022 | 2020 | APRICITY THERAPEUTICS, INC. | 953 INDIANA ST | SAN FRANCISCO | CA | 94107-3007 | SAN FRANCISCO | USA | R43FD006909 | Drug Transporters in Farm Animals | 000 | 1 | FDA | 9/14/2022 | $0 |
| | 2022 | 2019 | APRICITY THERAPEUTICS, INC. | 953 INDIANA ST | SAN FRANCISCO | CA | 94107-3007 | SAN FRANCISCO | USA | R43GM131477 | A Transporter Platform Technology For Discovery of Drugs to Treat Autoimmune Disease | 000 | 1 | NIH | 7/26/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $0 ) |
| | 2021 | 2020 | APRICITY THERAPEUTICS, INC. | 953 INDIANA ST | SAN FRANCISCO | CA | 94107-3007 | SAN FRANCISCO | USA | R43FD006909 | Drug Transporters in Farm Animals | 000 | 1 | FDA | 7/8/2021 | $0 |
| | 2021 | 2019 | APRICITY THERAPEUTICS, INC. | 953 INDIANA ST | SAN FRANCISCO | CA | 94107-3007 | SAN FRANCISCO | USA | R43GM131477 | A Transporter Platform Technology For Discovery of Drugs to Treat Autoimmune Disease | 000 | 1 | NIH | 4/15/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $168,000 ) |
| | 2020 | 2020 | APRICITY THERAPEUTICS, INC. | 953 INDIANA ST | SAN FRANCISCO | CA | 94107-3007 | SAN FRANCISCO | USA | R43FD006909 | Drug Transporters in Farm Animals | 000 | 1 | FDA | 8/18/2020 | $168,000 |
| | 2020 | 2019 | APRICITY THERAPEUTICS, INC. | 953 INDIANA ST | SAN FRANCISCO | CA | 94107-3007 | SAN FRANCISCO | USA | R43GM131477 | A Transporter Platform Technology For Discovery of Drugs to Treat Autoimmune Disease | 001 | 1 | NIH | 7/17/2020 | $0 |
| | 2020 | 2019 | APRICITY THERAPEUTICS, INC. | 953 INDIANA ST | SAN FRANCISCO | CA | 94107-3007 | SAN FRANCISCO | USA | R43GM131477 | A Transporter Platform Technology For Discovery of Drugs to Treat Autoimmune Disease | 000 | 1 | NIH | 2/7/2020 | $0 |
| | 2020 | 2017 | APRICITY THERAPEUTICS, INC. | 953 INDIANA ST | SAN FRANCISCO | CA | 94107-3007 | SAN FRANCISCO | USA | R43CA206705 | Development of a Pharmacoprotector for Platinum Toxicities | 000 | 1 | NIH | 3/13/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $223,334 ) |
| | 2019 | 2019 | APRICITY THERAPEUTICS, INC. | 67 JENNINGS LN | ATHERTON | CA | 94027-3017 | SAN MATEO | USA | R43GM131477 | A Transporter Platform Technology For Discovery of Drugs to Treat Autoimmune Disease | 000 | 1 | NIH | 5/16/2019 | $223,334 |
| | 2019 | 2017 | APRICITY THERAPEUTICS, INC. | 67 JENNINGS LN | ATHERTON | CA | 94027-3017 | SAN MATEO | USA | R43CA206705 | Development of a Pharmacoprotector for Platinum Toxicities | 000 | 1 | NIH | 12/5/2018 | $0 |
| | 2019 | 2017 | APRICITY THERAPEUTICS, INC. | 67 JENNINGS LN | ATHERTON | CA | 94027-3017 | SAN MATEO | USA | R43CA206705 | Development of a Pharmacoprotector for Platinum Toxicities | 001 | 1 | NIH | 9/5/2019 | $0 |
| | 2019 | 2016 | APRICITY THERAPEUTICS, INC. | 953 INDIANA ST | SAN FRANCISCO | CA | 94107-3007 | SAN FRANCISCO | USA | R43CA177013 | Development of Transporter Targeted Platinum Drugs for Glioblastoma | 000 | 1 | NIH | 10/22/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $225,000 ) |
| | 2017 | 2017 | APRICITY THERAPEUTICS, INC. | 67 JENNINGS LN | ATHERTON | CA | 94027-3017 | SAN MATEO | USA | R43CA206705 | Development of a Pharmacoprotector for Platinum Toxicities | 000 | 1 | NIH | 5/17/2017 | $225,000 |
|
| Issue Date FY: 2016 ( Subtotal = $216,990 ) |
| | 2016 | 2016 | APRICITY THERAPEUTICS INC | 953 INDIANA STREET | SAN FRANCISCO | CA | 94107 | SAN FRANCISCO | USA | R43CA177013 | Development of Transporter Targeted Platinum Drugs for Glioblastoma | 000 | 1 | NIH | 9/6/2016 | $216,990 |
|
| Issue Date FY: 2014 ( Subtotal = $190,000 ) |
| | 2014 | 2014 | APRICITY THERAPEUTICS INC | 67 JENNINGS LANE | ATHERTON | CA | 94027 | SAN MATEO | USA | R43CA183186 | Development of Transporter Targeted Platinum Drugs for Pediatric Tumor | 000 | 1 | NIH | 4/2/2014 | $190,000 |
| | 2014 | 2012 | APRICITY THERAPEUTICS INC | 67 JENNINGS LANE | ATHERTON | CA | 94027 | SAN MATEO | USA | R43CA174132 | Development of transporter targeted platinum drugs for neuroblastoma | 000 | 1 | NIH | 1/13/2014 | $0 |
|
| Issue Date FY: 2012 ( Subtotal = $172,738 ) |
| | 2012 | 2012 | APRICITY THERAPEUTICS INC | 67 JENNINGS LANE | ATHERTON | CA | 94027 | SAN MATEO | USA | R43CA174132 | Development of transporter targeted platinum drugs for neuroblastoma | 000 | 1 | NIH | 9/26/2012 | $172,738 |
|
|
